| 000 | 01248nam a22002657a 4500 | ||
|---|---|---|---|
| 005 | 20250422090829.0 | ||
| 008 | 250422b ph ||||| |||| 00| 0 eng d | ||
| 022 | _a0360-4039 | ||
| 040 | _cOCT | ||
| 100 | _aHughes, Elizabeth | ||
| 240 |
_aNursing 2024 / _hDecember 2024 |
||
| 245 |
_aBiosimilars vs. originators : _bA comprehensive guide for nurses on efficacy, safety, and patient care / _cby: Elizabeth Hughes, Sharon Tymkiv, and Karen Vuckovic |
||
| 300 |
_aVol 54 (12) pages 28-35 : _billustrations ; _c27 cm |
||
| 500 | _aAbstract: Biosimilars can potentially increase patient treatment options, allowing access to expensive biologic medications. As frontline caregivers, nurses are uniquely positioned to educate patients on their safety and effectiveness. This article discusses biosimilars and standard terms, their development process, and strategies for nurses to provide effective patient education about these medications. | ||
| 650 | _abiosimilar | ||
| 650 | _abiologic | ||
| 650 | _ainterchangeable biosimilar | ||
| 650 | _anursing education | ||
| 650 | _apatient education | ||
| 650 | _areference product | ||
| 650 | _aoriginator | ||
| 700 | _aTymkiv, Sharon | ||
| 700 | _aVuckovic, Karen | ||
| 942 |
_2ddc _cCR _n0 |
||
| 999 |
_c10341 _d10341 |
||